Drugs / Prenisolone sodium phosphate
re-read 3 minutes ago

Prenisolone sodium phosphate

Developed for
eye adnexa disorder
Investigated by
Evolutec Group

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00353964 — eye adnexa disorder Evolutec Group Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Prenisolone sodium phosphate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00353964 ↗